Breaking News Instant updates and real-time market news.

ABT

Abbott

$41.17

0.58 (1.43%)

07:45
10/19/16
10/19
07:45
10/19/16
07:45

Abbott reports Q3 adjusted EPS 59c, consensus 58c

Reports Q3 revenue $5.3B, consensus $5.29B.

  • 19

    Oct

  • 21

    Oct

  • 06

    Nov

ABT Abbott
$41.17

0.58 (1.43%)

09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.
09/29/16
ADAM
09/29/16
NO CHANGE
Target $53
ADAM
Buy
Alere risk-reward looks 'quite good' as deal debate nears end, says Canaccord
Canaccord analyst Mark Massaro said he is optimistic that a conclusion of Abbott (ABT) and Alere's (ALR) merger fight is "not far off" and he still believes Abbott will ultimately acquire Alere, though he also thinks the merger may be decided by a judge. Massaro puts a 65% probability on the likelihood the deal closes at the $56 deal price, a 30% chance that Abbott buys Alere at a lower price nearer to $50 per share, and only a 5% chance the deal breaks, making the risk-reward ratio in Alere shares at current levels "quite good," he tells investors. He trimmed his price target on Alere to $53 from $56 an keeps a Buy rating on the stock.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.
10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.

TODAY'S FREE FLY STORIES

NVS

Novartis

$86.73

0.08 (0.09%)

05:38
01/17/18
01/17
05:38
01/17/18
05:38
Hot Stocks
Novartis granted FDA priority review for Kymriah »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 08

    Feb

  • 16

    Feb

  • 23

    Apr

  • 17

    May

SKX

Skechers

$37.91

-0.64 (-1.66%)

05:38
01/17/18
01/17
05:38
01/17/18
05:38
Recommendations
Skechers analyst commentary  »

Skechers price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$100.69

-0.18 (-0.18%)

05:36
01/17/18
01/17
05:36
01/17/18
05:36
Hot Stocks
Walmart launches opioid disposal solution »

In an effort to help curb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

BLL

Ball Corp.

$38.39

0.49 (1.29%)

05:35
01/17/18
01/17
05:35
01/17/18
05:35
Upgrade
Ball Corp. rating change  »

Ball Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

PBYI

Puma Biotechnology

$90.85

-8.4 (-8.46%)

05:34
01/17/18
01/17
05:34
01/17/18
05:34
Recommendations
Puma Biotechnology analyst commentary  »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADTN

Adtran

$19.50

-0.2 (-1.02%)

05:30
01/17/18
01/17
05:30
01/17/18
05:30
Earnings
Adtran reports Q4 adj. EPS 5c, consensus (4c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

PSTG

Pure Storage

$16.16

-0.31 (-1.88%)

05:27
01/17/18
01/17
05:27
01/17/18
05:27
Upgrade
Pure Storage rating change  »

Pure Storage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

PSDO

Presidio

$17.74

-0.96 (-5.13%)

05:25
01/17/18
01/17
05:25
01/17/18
05:25
Downgrade
Presidio rating change  »

Presidio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$28.61

-0.28 (-0.97%)

05:24
01/17/18
01/17
05:24
01/17/18
05:24
Downgrade
Juniper rating change  »

Juniper downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

IDTI

Integrated Device

$31.75

-0.54 (-1.67%)

, MRVL

Marvell

$23.58

-0.26 (-1.09%)

05:22
01/17/18
01/17
05:22
01/17/18
05:22
Upgrade
Integrated Device, Marvell rating change  »

Integrated Device…

IDTI

Integrated Device

$31.75

-0.54 (-1.67%)

MRVL

Marvell

$23.58

-0.26 (-1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

WWR

Westwater Resources

$1.01

-0.0449 (-4.26%)

05:20
01/17/18
01/17
05:20
01/17/18
05:20
Hot Stocks
Westwater Resources confirms receipt of $1.5M from Laramide, provides update »

Westwater Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$163.85

0.71 (0.44%)

, AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

05:20
01/17/18
01/17
05:20
01/17/18
05:20
Upgrade
IBM, Amazon.com, Microsoft rating change  »

IBM upgraded to…

IBM

IBM

$163.85

0.71 (0.44%)

AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

MSFT

Microsoft

$88.35

-1.25 (-1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 31

    Jan

  • 07

    Feb

  • 18

    Mar

HPQ

HP Inc.

$22.88

-0.04 (-0.17%)

05:15
01/17/18
01/17
05:15
01/17/18
05:15
Downgrade
HP Inc. rating change  »

HP Inc. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

WPZ

Williams Partners

$43.01

-0.18 (-0.42%)

05:14
01/17/18
01/17
05:14
01/17/18
05:14
Downgrade
Williams Partners rating change  »

Williams Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$32.59

-0.62 (-1.87%)

05:14
01/17/18
01/17
05:14
01/17/18
05:14
Downgrade
Williams rating change  »

Williams downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGYF

Whitecap Resources

$7.69

0.0258 (0.34%)

05:13
01/17/18
01/17
05:13
01/17/18
05:13
Upgrade
Whitecap Resources rating change  »

Whitecap Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WES

Western Gas Partners

05:11
01/17/18
01/17
05:11
01/17/18
05:11
Downgrade
Western Gas Partners rating change  »

Western Gas Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

WGP

Western Gas Equity

$41.76

-0.36 (-0.85%)

05:11
01/17/18
01/17
05:11
01/17/18
05:11
Downgrade
Western Gas Equity rating change  »

Western Gas Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

VLP

Valero Energy Partners

$46.58

-0.11 (-0.24%)

05:11
01/17/18
01/17
05:11
01/17/18
05:11
Downgrade
Valero Energy Partners rating change  »

Valero Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

TRGP

Targa Resources

$50.75

-0.69 (-1.34%)

05:10
01/17/18
01/17
05:10
01/17/18
05:10
Upgrade
Targa Resources rating change  »

Targa Resources upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

PAGP

Plains GP Holdings

$23.41

-0.73 (-3.02%)

05:09
01/17/18
01/17
05:09
01/17/18
05:09
Downgrade
Plains GP Holdings rating change  »

Plains GP Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

PAA

Plains All American

$22.90

-1.06 (-4.42%)

05:09
01/17/18
01/17
05:09
01/17/18
05:09
Downgrade
Plains All American rating change  »

Plains All American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 07

    Feb

PSXP

Phillips 66 Partners

$55.73

0.58 (1.05%)

05:09
01/17/18
01/17
05:09
01/17/18
05:09
Downgrade
Phillips 66 Partners rating change  »

Phillips 66 Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

OKE

Oneok

$58.80

0.13 (0.22%)

05:08
01/17/18
01/17
05:08
01/17/18
05:08
Upgrade
Oneok rating change  »

Oneok upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPLX

MPLX

$38.28

-0.5 (-1.29%)

05:07
01/17/18
01/17
05:07
01/17/18
05:07
Downgrade
MPLX rating change  »

MPLX downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.